| Code | CSB-MP005271HU |
| Abbreviation | Recombinant Human CFD protein (Active) |
| MSDS | |
| Size | $220 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
Complement factor D catalyzes the rate-limiting step of the alternative pathway by cleaving factor B within the C3bB complex, making it a critical control point for complement-mediated immune responses. This full-length mature protein (aa 26–253) demonstrates specific antibody binding with an EC50 of 31.86–39.21 ng/mL in functional ELISA, providing quantitative evidence that the recombinant protein retains native epitope presentation suitable for complement activation assays and inhibitor screening targeting the alternative pathway. The combination of >95% purity and <1.0 EU/μg endotoxin meets the quality thresholds commonly required for hemolytic assays and opsonization studies, where contaminating proteases or inflammatory triggers would confound interpretation of complement-dependent lysis or phagocytosis. Researchers investigating immune evasion mechanisms or validating complement ELISA protocols can use this C-terminal His-tagged protein as a positive control with defined binding characteristics.
There are currently no reviews for this product.